EMG appoints two new senior members
pharmafile | April 4, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing |Â Â EMG, Matthew Speers, Steve Turley, UCBÂ
A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG).
EMG is the voice of research-driven UK pharma companies globally headquartered on the continent, and has a focus on ensuring UK patient access to modern medicines.
Steve Turley, managing director of Lundbeck, has been elected as the new chair for the 2012-13 term of office, replacing UCB managing director Matthew Speers.
Robin Bhattacherjee, the general manager of Actelion in the UK and Ireland, is appointed as the new vice-chair.
Mike Sumpter, chief executive of Servier Laboratories, will continue as the Group’s treasurer.
Related Content

UCB presents positive results for fenfluramine in CDKL5 deficiency disorder
UCB has announced positive results from its phase 3 GEMZ study, showing that fenfluramine can …

UCB announces first-in-patient trial success for galvokimig in atopic dermatitis
UCB has reported positive early clinical trial results for galvokimig, an investigational therapy for adults …

Rare and severe epilepsies – current treatments and advance therapeutics
The current forms of immunotherapy, how T cell therapy works and what the future holds





